Waqas Ahmed
University of South Alabama
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Waqas Ahmed.
Journal of the American College of Cardiology | 2012
Jochen Wöhrle; Mariusz Zadura; Sven Möbius-Winkler; Matthias Leschke; Christian F. Opitz; Waqas Ahmed; Paul Barragan; Jean-Philippe Simon; Graham Cassel; Bruno Scheller
OBJECTIVES This study sought to assess the safety and efficacy of paclitaxel-coated balloon (PCB) angioplasty in an international, multicenter, prospective, large-scale registry study. BACKGROUND In small randomized trials, PCB angioplasty was superior to uncoated balloon angioplasty for treatment of bare-metal stent (BMS) and drug-eluting stent (DES) restenosis. METHODS Patients treated with SeQuent Please PCBs were included. The primary outcome measure was the clinically driven target lesion revascularization (TLR) rate at 9 months. RESULTS At 75 centers, 2,095 patients with 2,234 lesions were included. The TLR rate was 5.2% after 9.4 months. Definite vessel thrombosis occurred in 0.1%. PCB angioplasty was performed in 1,523 patients (72.7%) with DES or BMS restenosis and 572 patients (27.3%) with de novo lesions. The TLR rate was significantly lower in patients with PCB angioplasty for BMS restenosis compared with DES restenosis (3.8% vs. 9.6%, p < 0.001). The TLR rate did not differ for PCB angioplasty of paclitaxel-eluting stent and non-paclitaxel-eluting sten restenosis (8.3% vs. 10.8%, p = 0.46). In de novo lesions (small vessels), the TLR rate was low and did not differ between PCB angioplasty with and without additional BMS implantation (p = 0.31). CONCLUSIONS PCB angioplasty in an all-comers, prospective, multicenter registry was safe and confirmed in a large population the low TLR rates seen in randomized clinical trials. PCB angioplasty was more effective in BMS restenosis compared with DES restenosis, with no difference regarding the type of DES.
The American Journal of the Medical Sciences | 2003
Ernesto Umana; Waqas Ahmed; Martin A. Alpert
Valvular and perivalvular involvement in end-stage renal disease (ESRD) is most commonly manifested as mitral annular calcification and aortic valve calcification. Both mitral and aortic valve calcification (MAC) occur more frequently and at younger age in those with ESRD than in those with normal renal function. Aortic valve calcification progresses to aortic stenosis more commonly and at a more accelerated rate than in the general population. Altered calcium and phosphate metabolism are thought to predispose to these valvular and perivalvular abnormalities. No treatment is necessary for MAC unless severe mitral regurgitation or stenosis occur (both are rare). Mitral valve repair or replacement and aortic valve replacement are indicated for severe symptomatic valve stenosis or regurgitation, albeit at a higher risk than in those with normal renal function. Infective endocarditis may complicate MAC or aortic stenosis in patients with ESRD and is associated with a high mortality rate in such patients.
Angiology | 2006
Ernesto Umana; Waqas Ahmed; Matthew A. Fraley; Martin A. Alpert
To assess the effect of obesity on blood pressure measurement the authors obtained simultaneous oscillometric and intraarterial systolic and diastolic blood pressures on 188 lean, overweight, class I/II obese, and class III obese subjects. Oscillometric arm cuff/bladder size was selected in accordance with standard guidelines. Oscillometry significantly underestimated systolic and significantly overestimated diastolic blood pressures in each of the 4 weight groups studied. The differences between oscillometric and intraarterial systolic and diastolic pressures were not significantly different among lean, overweight, class I/II obese, and class III obese subjects. Thus, obesity per se does not influence the accuracy of blood pressure measurement. However, oscillometric blood pressure measurement is associated with significant error when compared to intraarterial blood pressure.
The American Journal of the Medical Sciences | 2001
Waqas Ahmed; Margaret A. Flynn; Martin A. Alpert
Weight reduction diets may reduce the severity of risk factors for coronary heart disease such as diabetes mellitus, hypertension, and dyslipidemia. Several case reports and small studies of patients receiving starvation diets have reported hypotension and sudden cardiac death. Myofibrillar damage was documented in 1 case. Very-low-calorie diets are generally safe and well-tolerated. However, low QRS voltage, QT interval prolongation, and both nonsustained ventricular arrhythmias and sudden cardiac death have been described in subjects treated with such diets. Orthostatic hypotension may complicate very-low-calorie protein diets because of sodium depletion and depressed sympathetic nervous system activity. Bariatric surgery is associated with disproportionately high mortality rates in both the perioperative and postoperative periods.
Angiology | 2007
Waqas Ahmed; Saman Zafar; Ali Yawar Alam; Naveed Ahktar; Mumtaz Ali Shah; Martin A. Alpert
Plasma B-type natriuretic peptide (BNP) levels were obtained from 146 patients with unstable angina pectoris, non—ST-segment elevation myocardial infarction (MI), or ST-segment elevation MI to determine their value in predicting the presence of new heart failure, recurrent MI or ischemia, or death 1 month after the index event. Patients with elevated plasma BNP levels (>80 pg/mL) had a significantly higher incidence of new heart failure and all-cause mortality than those with a normal plasma BNP level (≤80 pg/mL). Early revascularization with percutaneous intervention or coronary artery bypass grafting significantly reduced the incidence of new heart failure and all-cause mortality in patients with an elevated plasma BNP level, but had no effect on individual outcomes in the normal plasma BNP subgroup.
Annals of Clinical Psychiatry | 2000
Shareh O. Ghani; Waqas Ahmed; Luis A. Marco
We report an unusual case of thrombocytopenia associated with neuroleptic malignant syndrome (NMS). A 31-year-old Black male with a history of hypertension, partial seizures, and schizophrenia developed acute rigidity closely followed by severe hyperpyrexia (temperature 102 degree F), tachypnea, and tachycardia. His home medications at the time of presentation included propanolol 10 mg tid, haloperidol 10 mg bid, sodium valproate 500 mg bid, benztropine 1 mg bid, and haloperidol decanoate 100 mg i.m. every 3 weeks, from another psychiatric facility. Despite vigorous therapy for the hyperthermia, he rapidly developed significant hypoxia requiring mechanical ventilation. A diagnosis of neuroleptic malignant syndrome was made and the patient continued to receive aggressive supportive care. On hospital day 2 his platelet count dropped to 47,000/microl and bottomed out at 36,000/microl by day 3 with other blood cell counts remaining within normal limits. Over the next few days he showed rapid clinical improvement with normalization of his blood chemistries and he was discharged home after 5 days of hospitalization in good condition.
The Internet Journal of Cardiology | 2001
Waqas Ahmed; Ernesto Umana; Painter Jack
Journal of the American College of Cardiology | 2011
Aravinda Nanjundappa; Ashwin Bhirud; Waqas Ahmed; Nick DePriest; Robert S. Dieter; Sangeeta Mandapaka; Stephanie N. Thompson
Journal of the American College of Cardiology | 2011
Aravinda Nanjundappa; Nick DePriest; Waqas Ahmed; Ashwin Bhirud; Robert S. Dieter; Sangeeta Mandapaka; Stephanie N. Thompson
Archive | 2010
Eoin O'Brien; Bernard Waeber; G. Parati; Jan A Staessen; Martin G. Myers; Elizabeth Umana; Waqas Ahmed; Matthew A. Fraley; Martin A. Alpert